Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Cancer Research|December 17, 2011
Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironmentAlexander M Lesokhin, Tobias M Hohl, Shigehisa Kitano, et al.
The Journal of Experimental Medicine|April 1, 2009
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune responseGabrielle A Rizzuto, Taha Merghoub, Daniel Hirschhorn-Cymerman, et al.
Cancer Immunology Research|May 22, 2014
Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomesShigehisa Kitano, Michael A Postow, Carly G K Ziegler, et al.
Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.
Nature Cancer|August 26, 2024
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trialShambavi Richard, Alexander M Lesokhin, Barry Paul, et al.
Leukemia & Lymphoma|June 1, 2022
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approachOscar B Lahoud, Heather Landau, James Nguyen, et al.
Clinical Biochemistry|September 25, 2016
Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral bloodKazunori Murata, Samuel I McCash, Brittany Carroll, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Correlating High-dimensional longitudinal microbial features with time-varying outcomes with FLORALTeng Fei, Victoria Donovan, Tyler Funnell, et al.
Nature Communications|August 28, 2021
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myelomaKylee H Maclachlan, Even H Rustad, Andriy Derkach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple MyelomaMalin Hultcrantz, Even H Rustad, Venkata Yellapantula, et al.
Pageof 9